Explore new DOJ and HHS healthcare self-disclosure policies, including False Claims Act eligibility, repayment terms and key deadlines for healthcare companies.
Adnan Bekdur has joined the firm as a partner in its corporate & securities practice, establishing a dedicated corporate ...
The Dechert Antitrust Merger Investigation Timing Tracker (DAMITT) is a quarterly study reporting on trends in significant ...
This is the second in our series of follow-up pieces to CFO Market Update 2026, each taking a closer look at a topic we ...
A federal court in California denied class certification in a vehicle defect suit because evidence of the manufacturer’s ...
The SEC’s Division of Examinations (“EXAMS”) issued its 2027 examination priorities, which reinforce fiduciary obligations ...
Dechert advised CohnReznick, a leading professional services firm, on its strategic acquisition of the Aldrich group of ...
The Central Bank has advised that in order to focus over the Christmas period on applications that are at an advanced stage and likely considered to be authorised or approved prior to year-end, the ...
Dechert Files Comment Letter in Response to the CFTC’s Proposed CPO ...
Hrishikesh N. Hari (“Hrishi”) serves as Co-Chair of the firm's National Security Group in Washington, D.C. He advises private equity investors, asset managers, financial institutions and major ...
The Tokenisation FAQ does not purport to be a complete guide to tokenisation under Luxembourg law, but rather lists recurrent questions raised with the CSSF in this context. Consistent with its ...
The SEC’s proposed amendments to Rule 17a-7 would expand the scope of securities eligible for cross trading beyond those with “readily available market quotations” (Level 1 securities) to include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results